8i Acquisition 2 Corp.
Status: Deal Closed
U=S+W+R
W=S/2@$11.50
R=S/10
| IPO Proceeds, $M | $86.25M |
|---|---|
| IPO Date | Nov 22, 2021 |
| CEO | Meng Dong (James) Tan |
| Left Lead | Maxim |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 12 + (2*3) |
| IPO Sector |
General
Asia |
| IPO Geography | Asia |
| Target Company | EUDA Health |
| Deal Announced | Apr 12, 2022 |
| Deal Size, $M | $262.00M |
| Deal Sector | Healthcare |
| Deal Geography | Asia |
| SEC Filings | www.sec.gov |
| Approval Vote | Nov 10, 2022 |
| Amendment Vote | TBD |
| Closing Date | Nov 17, 2022 |
Formerly LAX
EUDA
EUDAW
| Price | $4.38 |
|---|---|
| Last closing price | $4.34 |
| H/L, today | $4.12 / $4.49 |
| H/L, 52-week | $0.43 / $6.34 |
| Volume, today | 104,043 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on 8i Acquisition 2 Corp.:
- Structure and cap table
- 5 directors & officers
- 28 filings and events
- 1 underwriters
- 1 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Meng Dong (James) Tan | 60 | CEO & Chairman |
| Guan Hong (William) Yap | 57 | CFO & Director |
| Kwong Yeow Liew | 67 | Director |
| Ajay Rajpal | 52 | Director |
| Alexander Arrow | 50 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Maxim | BR | 7,500,000 | units |
| 7,500,000 | units | ||
| Up-Front UW fee | 4.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.